Researchers have identified four key biomarkers in the fluid surrounding the brain and spinal cord that may be used to assess response to MSC-NP, a type of stem cell therapy currently in early clinical testing for progressive forms of multiple sclerosis (MS). The levels of these four molecules —…
Discussion
Regulators in the European Union (EU) have recommended that the infusion therapy Ocrevus (ocrelizumab) be approved to treat children and teens, ages 10 and older, who have relapsing forms of multiple sclerosis (MS). The recommendation comes from the Committee for Medicinal Products for Human Use (CHMP), an arm…
Discussion
Tiziana Life Sciences has signed a deal with strategic partners to support a clinical trial designed to test its experimental nasal therapy foralumab in people with hard-to-treat relapsing-remitting multiple sclerosis (RRMS). Under the signed Memorandum of Understanding (MOU), the collaboration involves Tiziana, The King Abdullah International Medical Research…
Discussion
Among people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with higher depression severity, according to a small study from Egypt. The study showed that people with RRMS had substantially higher rates of at least moderate depression than people without multiple sclerosis (MS). More severe depression was also…
Discussion
Medically indicated cesarean sections (C-sections) before 39 weeks of gestation, or full term pregnancy, may be more frequent among women with multiple sclerosis (MS) than in those without the disease, a study found. However, this difference was not linked to MS itself, with most commonly reported reasons for early…
Get regular updates to your inbox.
